Immucell (ICCC) Tax Provisions (2010 - 2026)

Immucell (ICCC) has reported Tax Provisions for 17 consecutive years, with $45950.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Tax Provisions rose 2313.34% year-over-year to $45950.0; the trailing twelve-month figure through Jun 2026 stood at -$171930.0 (up 61.76% YoY), and the FY2025 full-year result was -$215976.0, up 52.09% from the prior year.
• Tax Provisions improved to $45950.0 in Q2 2026 per ICCC's latest filing, from -$224240.0 in the prior quarter.
• Across five years, Tax Provisions topped out at $45950.0 in Q2 2026 and bottomed at -$1.2 million in Q4 2023.
• Historically, Tax Provisions has averaged -$138505.1 across 5 years, with a median of $1340.0 in 2024.
• The sharpest annual moves came in 2022 and 2026: Tax Provisions plunged 2241.53% in 2022, then jumped 2313.34% in 2026.
• Over 5 years, Tax Provisions stood at -$528250.0 in 2022, then slumped by 130.0% to -$1.2 million in 2023, then jumped by 62.57% to -$454800.0 in 2024, then soared by 50.69% to -$224240.0 in 2025, then soared by 120.49% to $45950.0 in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $45950.0, -$224240.0, and $4456.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.